BSEShelter Pharma LtdMinimalNeutral
Announced Tue, 30 Sept · 17:44 IST

Declaration of Voting Result and Scrutinizer Report

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Shelter Pharma Ltd held its 18th Annual General Meeting on September 30, 2025, at its registered office in Himmatnagar, Gujarat. All 5 ordinary resolutions were passed with 100% votes in favour and no votes against. Total votes polled were 62,97,000 (54.47% of the 1,15,59,792 outstanding shares), with promoter participation at 99.95% and public participation at just 4.57%. The approved resolutions included adoption of audited FY25 financial statements, declaration of a 3.5% dividend (Rs. 0.35 per equity share), re-appointment of Managing Director Mustaqim Nisarahmed Sabugar (DIN: 01456841) via rotation, appointment of M/s Alvi & Associates as new Statutory Auditors replacing the resigning auditor, and appointment of M/s Murtuza Mandorwala & Associates as Secretarial Auditors.

Likely market impact

Shareholders will receive a dividend of Rs. 0.35 per share for FY25. The change in statutory auditor (replacing a resigning auditor) is a routine corporate housekeeping matter, and the re-appointment of the promoter Managing Director maintains leadership continuity.